Contribution of APCs to mucosal-associated invariant T cell activation in infectious disease and cancer

9Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

APCs such as monocytes and dendritic cells are among the first cells to recognize invading pathogens and initiate an immune response. The innate response can either eliminate the pathogen directly, or through presentation of Ags to T cells, which can help to clear the infection. Mucosal-associated invariant T (MAIT) cells are among the unconventional T cells whose activation does not involve the classical co-stimulation during Ag presentation. MAIT cells can be activated either via presentation of unconventional Ags (such as riboflavin metabolites) through the evolutionarily conserved major histocompatibility class I-like molecule, MR1, or directly by cytokines such as IL-12 and IL-18. Given that APCs produce cytokines and can express MR1, these cells can play an important role in both pathways of MAIT cell activation. In this review, we summarize evidence on the role of APCs in MAIT cell activation in infectious disease and cancer. A better understanding of the interactions between APCs and MAIT cells is important in further elucidating the role of MAIT cells in infectious diseases, which may facilitate the design of novel interventions such as vaccines.

Cite

CITATION STYLE

APA

Shey, M. S., Balfour, A., Wilkinson, K. A., & Meintjes, G. (2018, May 1). Contribution of APCs to mucosal-associated invariant T cell activation in infectious disease and cancer. Innate Immunity. SAGE Publications Ltd. https://doi.org/10.1177/1753425918768695

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free